These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19508892)

  • 1. Design for optimization of nanoparticles integrating biomaterials for orally dosed insulin.
    Woitiski CB; Veiga F; Ribeiro A; Neufeld R
    Eur J Pharm Biopharm; 2009 Sep; 73(1):25-33. PubMed ID: 19508892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colloidal carrier integrating biomaterials for oral insulin delivery: Influence of component formulation on physicochemical and biological parameters.
    Woitiski CB; Neufeld RJ; Ribeiro AJ; Veiga F
    Acta Biomater; 2009 Sep; 5(7):2475-84. PubMed ID: 19362890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitosan/Albumin Coating Factorial Optimization of Alginate/Dextran Sulfate Cores for Oral Delivery of Insulin.
    Pessoa B; Collado-Gonzalez M; Sandri G; Ribeiro A
    Mar Drugs; 2023 Mar; 21(3):. PubMed ID: 36976228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral bioavailability of insulin contained in polysaccharide nanoparticles.
    Sarmento B; Ribeiro A; Veiga F; Ferreira D; Neufeld R
    Biomacromolecules; 2007 Oct; 8(10):3054-60. PubMed ID: 17877397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles.
    Cui F; Qian F; Zhao Z; Yin L; Tang C; Yin C
    Biomacromolecules; 2009 May; 10(5):1253-8. PubMed ID: 19292439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silica nanoparticle coated liposomes: a new type of hybrid nanocapsule for proteins.
    Mohanraj VJ; Barnes TJ; Prestidge CA
    Int J Pharm; 2010 Jun; 392(1-2):285-93. PubMed ID: 20363300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing insulin's secondary structure after entrapment into alginate/chitosan nanoparticles.
    Sarmento B; Ferreira DC; Jorgensen L; van de Weert M
    Eur J Pharm Biopharm; 2007 Jan; 65(1):10-7. PubMed ID: 17101268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of insulin nanoparticles using chitosan and its quaternized derivatives.
    Bayat A; Larijani B; Ahmadian S; Junginger HE; Rafiee-Tehrani M
    Nanomedicine; 2008 Jun; 4(2):115-20. PubMed ID: 18339584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and optimization of solid lipid nanoparticles of buspirone HCl for enhancement of its oral bioavailability.
    Varshosaz J; Tabbakhian M; Mohammadi MY
    J Liposome Res; 2010 Dec; 20(4):286-96. PubMed ID: 19958118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and characterization of new insulin containing polysaccharide nanoparticles.
    Sarmento B; Ribeiro A; Veiga F; Ferreira D
    Colloids Surf B Biointerfaces; 2006 Dec; 53(2):193-202. PubMed ID: 17049214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin/chitosan nanoparticle carriers prepared by polyelectrolyte complexation.
    Liu Z; Jiao Y; Liu F; Zhang Z
    J Biomed Mater Res A; 2007 Dec; 83(3):806-12. PubMed ID: 17559117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facilitated nanoscale delivery of insulin across intestinal membrane models.
    Woitiski CB; Sarmento B; Carvalho RA; Neufeld RJ; Veiga F
    Int J Pharm; 2011 Jun; 412(1-2):123-31. PubMed ID: 21501675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
    Yin L; Ding J; He C; Cui L; Tang C; Yin C
    Biomaterials; 2009 Oct; 30(29):5691-700. PubMed ID: 19615735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized preparation of insulin-lauryl sulfate complex loaded poly (lactide-co-glycolide) nanoparticles using response surface methodology.
    Shi K; Cui F; Yamamoto H; Kawashima Y
    Pharmazie; 2008 Oct; 63(10):721-5. PubMed ID: 18972833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological effect of orally delivered insulin facilitated by multilayered stable nanoparticles.
    Woitiski CB; Neufeld RJ; Veiga F; Carvalho RA; Figueiredo IV
    Eur J Pharm Sci; 2010 Nov; 41(3-4):556-63. PubMed ID: 20800679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex.
    Cafaggi S; Russo E; Stefani R; Leardi R; Caviglioli G; Parodi B; Bignardi G; De Totero D; Aiello C; Viale M
    J Control Release; 2007 Aug; 121(1-2):110-23. PubMed ID: 17601625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and characterization of amphotericin B-chitosan-dextran sulfate nanoparticles.
    Tiyaboonchai W; Limpeanchob N
    Int J Pharm; 2007 Feb; 329(1-2):142-9. PubMed ID: 17000065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery.
    Sajeesh S; Sharma CP
    Int J Pharm; 2006 Nov; 325(1-2):147-54. PubMed ID: 16859846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Box-Behnken experimental design for the formulation and optimisation of selenomethionine-loaded chitosan nanoparticles coated with zein for oral delivery.
    Vozza G; Danish M; Byrne HJ; Frías JM; Ryan SM
    Int J Pharm; 2018 Nov; 551(1-2):257-269. PubMed ID: 30153488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depot formulation of vasoactive intestinal peptide by protamine-based biodegradable nanoparticles.
    Wernig K; Griesbacher M; Andreae F; Hajos F; Wagner J; Mosgoeller W; Zimmer A
    J Control Release; 2008 Sep; 130(2):192-8. PubMed ID: 18601963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.